Gapping up
In reaction to strong earnings/guidance:
- AIR +19%, TIGR +16.3%, NKE +8.4%, SCS +4.5%, WGO +4.4%, NOAH +4.1%
Other news:
- CTSO +64.9% (CytoSorb has now been used in more than 70 COVID-19 patients to help treat cytokine storm and life-threatening complications)
- TWO +34.1% ( to suspend Q1 common and preferred stock dividends)
- EVRI +10.5% (withdraws its 2020 guidance)
- EQNR +5.9% (presents updated outlook for 2020 and an around $3 bln action plan to strengthen the financial resilience)
- CAMP +4.6% (new CEO)
- AYR +3.5% (receives final regulatory approval in connection with pending merger)
- EXEL +2.2% (Exelixis' partner Takeda (TAK) receives approval in Japan for CABOMETYX )
- HNGR +1% (withdraws its 2020 guidance)
Analyst comments:
- TOT +4.3% (upgraded to Outperform from Mkt Perform at Bernstein)
- ROST +4.1% (upgraded to Buy from Sell at Goldman)
- KO +2.5% ( upgraded to Buy from Hold at DZ Bank)
- KBH +2.5% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- LUV +2.5% (upgraded to Outperform from Market Perform at Cowen)
- TJX +1.7% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- AAPL +0.5% (upgraded to Buy from Hold at Deutsche Bank)